Mimedx PE ratio MDXG
Share price divided by earnings per share over the last twelve months, since 2015.
- Today, Nov 2, 2026
- n/m
- losses over the last year
- Last meaningful
- 97.8×
- Oct 2026
- 10-year median
- 21.0×
- 10-year range
- 3.7× to 119×
- Peer median
- 21.3×
Mimedx has no meaningful PE ratio today: it lost $0.13 a share over the last twelve months, and a PE needs earnings.
It was last meaningful in Oct 2026, at 97.8×.
On the days it had one over the last ten years, its median was 21.0×, from 3.7× in Dec 2018 to 119× in Sep 2026.
PE ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 97.8× | 10.7× | 119× |
| 2025 | 25.6× | 16.6× | 34.8× |
| 2024 | 19.6× | 9.1× | 22.1× |
| 2023 | n/m a value too high to mean anything | ||
| 2022 | n/m a value too high to mean anything | ||
| 2021 | n/m a value too high to mean anything | ||
| 2020 | 16.6× | 16.6× | 24.3× |
| 2019 | 23.4× | 6.6× | 23.9× |
| 2018 | 4.8× | 3.7× | 55.5× |
| 2017 | 40.7× | 35.8× | 115× |
| 2016 | 52.1× | 27.3× | 58.6× |
| 2015 | 52.1× | 43.1× | 218× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Mimedx's size, closest first, today.
| Company | PE ratio |
|---|---|
| MDXGMimedx | n/m |
| TCMDTactile Systems Technology | 21.2× |
| EMBCEmbecta | 4.2× |
| MOVMovado | 17.7× |
| INFUInfuSystem | 33.8× |
| IRMDIradimed | 42.5× |
| UTMDUtah Medical Products | 21.5× |
| IARTIntegra Lifesciences | 80.1× |
| BVSBioventus | 17.1× |
| PDEXPro DEX | 15.9× |
| STAAStaar Surgical | 356× |
| Peer median | 21.3× |
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Mimedx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.